niclosamide has been researched along with Cancer of Liver in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, N; Eissa, LA; El-Karef, A; El-Sherbiny, IM; Yahia, S; Zeyada, MS | 1 |
| Alasadi, A; Chen, M; Collantes, J; Fadhil, N; Guo, J; Jin, S; Montelione, GT; Swapna, GVT; Tao, H | 1 |
| Chen, MJ; Chen, WS; Chien, MH; Ho, YC; Lai, SY; Yang, SF; Yang, YC; Yeh, CB | 1 |
| Choi, JH; Chung, YY; Jung, IH; Lim, GL; Park, SW; Park, YN | 1 |
| Deng, Q; Wang, J; Weng, S; Yu, Y; Yuan, Y; Zhou, L; Zhu, J | 1 |
| Butte, AJ; Chen, B; Chua, MS; Gill, RM; Ma, L; So, S; Wei, W; Yang, B | 1 |
| Helfman, DM | 1 |
| Fichtner, I; Kobelt, D; Lemm, M; Sack, U; Schlag, PM; Scudiero, D; Selby, M; Shoemaker, RH; Stein, U; Walther, W | 1 |
8 other study(ies) available for niclosamide and Cancer of Liver
| Article | Year |
|---|---|
Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways.
Topics: Animals; Anthelmintics; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Carriers; Liver Neoplasms; Male; Micelles; Nanoparticles; Niclosamide; Rats, Sprague-Dawley; Receptors, Notch; Signal Transduction; Wnt Signaling Pathway | 2020 |
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer.
Topics: Animals; Antinematodal Agents; Colonic Neoplasms; Ethanolamine; Humans; Liver Neoplasms; Mice; Niclosamide; Oxyclozanide | 2018 |
Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist-mediated CD10 expression.
Topics: Administration, Oral; Anthelmintics; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Down-Regulation; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Neprilysin; Niclosamide; RNA, Small Interfering; Twist-Related Protein 1 | 2018 |
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis.
Topics: Aminopyridines; Animals; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cyclic S-Oxides; Disease Models, Animal; Enzyme Activation; Humans; Inflammation; Interleukin-6; Janus Kinases; Liver; Liver Neoplasms; Morpholines; Niclosamide; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; STAT3 Transcription Factor; Zebrafish; Zebrafish Proteins | 2015 |
Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells.
Topics: Activating Transcription Factor 3; Activating Transcription Factor 4; Anthelmintics; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; eIF-2 Kinase; Flow Cytometry; Gene Knockout Techniques; Hep G2 Cells; Humans; In Situ Nick-End Labeling; Liver Neoplasms; Niclosamide; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transcription Factor CHOP; Transcriptional Activation; Up-Regulation | 2016 |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Proliferation; Chaperonins; Computational Biology; Computer Simulation; Databases, Genetic; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Ethanolamine; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hep G2 Cells; HSP90 Heat-Shock Proteins; Humans; Liver Neoplasms; Male; Molecular Chaperones; Niacinamide; Niclosamide; Phenylurea Compounds; Signal Transduction; Sorafenib; Time Factors; Transcriptome; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Neoplasm Invasiveness; Niclosamide; Prognosis; RNA, Messenger; S100 Calcium-Binding Protein A4; S100 Proteins; Signal Transduction; Transplantation, Heterologous; Wnt Proteins | 2011 |
Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromatin Immunoprecipitation; Colonic Neoplasms; Disease Progression; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Infusions, Parenteral; Kaplan-Meier Estimate; Liver Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Niclosamide; Prognosis; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; S100 Calcium-Binding Protein A4; S100 Proteins; Signal Transduction; Time Factors; Transplantation, Heterologous; Tumor Stem Cell Assay; Wnt Proteins | 2011 |